| human | Q5 |
| P213 | ISNI | 0000000018398214 |
| P496 | ORCID iD | 0000-0002-7336-7458 |
| P214 | VIAF ID | 23077433 |
| P10832 | WorldCat Entities ID | E39PBJmtvRp89pwjFWCvXPm68C |
| P735 | given name | ??? | Q16390927 |
| ??? | Q16390927 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q38473170 | A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls. |
| Q40328974 | A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. |
| Q42950741 | Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction |
| Q91124975 | BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis |
| Q91619835 | Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers |
| Q36214308 | C-type Lectin Mincle Recognizes Glucosyl-diacylglycerol of Streptococcus pneumoniae and Plays a Protective Role in Pneumococcal Pneumonia |
| Q46062356 | Calgranulin B (S100A9/MRP14): a key molecule in idiopathic pulmonary fibrosis? |
| Q35974078 | Common patterns and disease-related signatures in tuberculosis and sarcoidosis |
| Q34359481 | Common variable immunodeficiency-associated granulomatous and interstitial lung disease |
| Q40657495 | Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography |
| Q81592735 | Eosinophilic cationic protein in bronchoalveolar lavage fluid of lung transplant patients |
| Q37164171 | Essential role of osteopontin in smoking-related interstitial lung diseases |
| Q39150142 | Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial |
| Q33908569 | Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry |
| Q35708762 | Immune response to Propionibacterium acnes in patients with sarcoidosis--in vivo and in vitro |
| Q37776188 | Immunologic response of sarcoidosis |
| Q40136175 | Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome |
| Q39470428 | Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis |
| Q35901288 | Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis |
| Q42366226 | Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)? |
| Q35054029 | Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation |
| Q34973462 | Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis |
| Q37585596 | Non-invasive biomarkers in pulmonary fibrosis |
| Q47548972 | Phenotypes of organ involvement in sarcoidosis |
| Q46920626 | Phenotyping sarcoidosis from a pulmonary perspective |
| Q35593081 | Prognostic Value of Malic Enzyme and ATP-Citrate Lyase in Non-Small Cell Lung Cancer of the Young and the Elderly |
| Q35619235 | Proteome analysis of bronchoalveolar lavage in pulmonary langerhans cell histiocytosis |
| Q94498591 | Proteomic characterization of idiopathic pulmonary fibrosis patients: stable versus acute exacerbation |
| Q42464328 | Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease |
| Q40178788 | Sarcoidosis - Recent Advances |
| Q36748168 | Sarcoidosis--immunopathogenetic concepts |
| Q83264263 | Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis |
| Q45369141 | Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis |
| Q94547016 | Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry |
| Q37241249 | The Diagnosis, Differential Diagnosis, and Treatment of Sarcoidosis |
| Q92711368 | The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation |
| Q84187810 | The analysis of tryptase in serum of sarcoidosis patients |
| Q85166712 | The impact of gas exchange measurement during exercise in pulmonary sarcoidosis |
| Q90689112 | The natural history of progressive fibrosing interstitial lung diseases |
| Q38055722 | The pathogenesis of pulmonary fibrosis: a moving target |
| Q38735705 | Trace metals in fluids lining the respiratory system of patients with idiopathic pulmonary fibrosis and diffuse lung diseases |
| Q38738737 | Transcriptome profiles in sarcoidosis and their potential role in disease prediction |
| Q28741912 | Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states |
Search more.